CNSY Latest Press Releases

-- November 4, 2026 --

Cerenome Secures National In-Network Agreement with Aetna for CNSide Globe Newswire 7:30 AM

-- October 29, 2026 --

Cerenome Completes Enrollment in Phase 2 ReSPECT-GBM Trial of REYOBIQ in Recurrent Glioblastoma Globe Newswire 7:30 AM

-- October 27, 2026 --

Cerenome to Present Interim Clinical Update on the ReSPECT-LM Trial of Multiple REYOBIQ Doses in Leptomeningeal Metastases Globe Newswire 7:30 AM

-- October 21, 2026 --

Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ Globe Newswire 7:30 AM

-- October 8, 2026 --

Cerenome Secures In-Network Agreement with Florida Blue for CNSide CSF Tumor Cell Enumeration and Molecular Profile Tests Globe Newswire 7:30 AM

-- October 6, 2026 --

Cerenome Launches CNSide CSF Molecular Profile Tests Globe Newswire 7:30 AM

-- September 30, 2026 --

Cerenome Expects $1.55 Million in CNSide Third Quarter Gross Billings Globe Newswire 7:30 AM

-- September 25, 2026 --

Cerenome to Hold CNSide Business Update Call on September 30, 2026 Globe Newswire 7:30 AM

-- September 22, 2026 --

Cerenome Secures In-Network Agreement with Blue Cross Blue Shield of Michigan, Expanding CNSide Contracted Coverage to Approximately 158 Million Covered Lives Globe Newswire 7:30 AM

-- September 16, 2026 --

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division Globe Newswire 7:30 AM

-- September 10, 2026 --

Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment Globe Newswire 7:15 AM

-- August 20, 2026 --

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines Globe Newswire 7:30 AM

-- August 14, 2026 --

Cerenome Reports Second Quarter 2026 Financial Results and Business Update Globe Newswire 4:15 PM

-- August 13, 2026 --

Cerenome Secures In-Network Agreement with Health Care Service Corporation, Expanding CNSide Contracted Coverage to Over 150 Million Covered Lives Globe Newswire 7:30 AM

-- August 6, 2026 --

Cerenome Selects XiFin Empower RCM for Revenue Cycle Management and Clearinghouse Services for CNSide Platform Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes